AMLX · NASDAQ · Biotechnology

Amylyx Pharmaceuticals (AMLX)

Developing avexitide-led therapies for endocrine and neurodegenerative diseases.

$32.95
After hours−0.05 (−0.15%)
At close$33.00(+1.88%)